Hsu, Li Yang

Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe

Han, E., Tan, M. M. J., Turk, E., Sridhar, D., Leung, G. M., Shibuya, K., Asgari, N., Oh, J., García-Basteiro, A. L., Hanefeld, J., et al. (2020) · The Lancet

COVID-19 epidemiological studiesCOVID-19 Prevention and Impact

Cited by 814

Are high-performing health systems resilient against the COVID-19 epidemic?

Legido-Quigley, H., Asgari, N., Teo, Y. Y., Leung, G. M., Oshitani, H., Fukuda, K., Cook, A. R., Hsu, L. Y., Shibuya, K., & Heymann, D. (2020) · The Lancet

Healthcare Systems and PracticesHealthcare Systems and Challenges

Cited by 563

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection

Le Bert, N., Clapham, H. E., Tan, A. T., Chia, W. N., Tham, C. Y. L., Lim, J. M., Kunasegaran, K., Tan, L. W. L., Dutertre, C.-A., Shankar, N., et al. (2021) · Journal of Experimental Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 330

Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis

Lewnard, J. A., Charani, E., Gleason, A., Hsu, L. Y., Khan, W. A., Karkey, A., Chandler, C. I. R., Mashe, T., Khan, E. A., Bulabula, A. N. H., et al. (2024) · The Lancet

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 220

Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region

Tan, T. Y., Hsu, L. Y., Alejandria, M. M., Chaiwarith, R., Chinniah, T., Chayakulkeeree, M., Choudhury, S., Chen, Y. H., Shin, J. H., Kiratisin, P., et al. (2016) · Medical Mycology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 139